European Journal of Heart Failure Lauds BioControl Medical’s Research on Vagus Nerve Stimulation for Treating HF

YEHUD, Israel & NEW HOPE, Minn.--(BUSINESS WIRE)--BioControl Medical has announced that the pilot clinical study of its CardioFit® vagus nerve stimulation system has been recognized as seminal original research in the European Journal of Heart Failure. According to a recent editorial, “the highly cited open-label Phase II study [of the CardioFit] by De Ferrari et al. demonstrated for the first time that chronic vagus nerve stimulation is associated with improvements in New York Heart Association (NYHA) class, 6 min[ute] walk test, left ventricular ejection fraction, and systolic volumes up to 1 year, [setting] the stage for further investigations and clinical trials in this new era of device thearapy.”1,2